C. Svensson

发表

Biotransformation of Drugs in Human Skin

C. K. Svensson, C. Svensson, 2009, Drug Metabolism and Disposition.

Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotype.

R. MacArthur, M. Doll, D. Hein, 2000, Pharmacogenetics.

Correction: Acetylator phenotype and genoype in patients infected with HIV: Discordance between methods for phenotype determination and genotype (Pharmacogenetics (2000) 10 (171-182))

R. MacArthur, M. Doll, D. Hein, 2000 .

Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes.

P. Woster, S. Roychowdhury, C. K. Svensson, 2005, Biochemical pharmacology.

Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone.

P. Woster, T. Reilly, C. K. Svensson, 1998, Biochemical pharmacology.

Representation of American blacks in clinical trials of new drugs.

C. K. Svensson, C. Svensson, 1989, JAMA.

Therapeutic Drug Monitoring in Saliva

C. K. Svensson, R. Drobitch, C. Svensson, 1992, Clinical pharmacokinetics.

Phenotypic and Genotypic Characterization of N -Acetylation

D. Hein, C. K. Svensson, C. Svensson, 2005 .

Clinical Pharmacokinetics of Pethidine: 1982

D. Edwards, C. K. Svensson, D. Lalka, 1982, Clinical pharmacokinetics.

Free Drug Concentration Monitoring in Clinical Practice

M. Woodruff, C. K. Svensson, D. Lalka, 1986 .

Enhanced Xenobiotic-Induced Hepatotoxicity and Kupffer Cell Activation by Restraint-Induced Stress

F. Khan, C. K. Svensson, S. Panuganti, 2006, Journal of Pharmacology and Experimental Therapeutics.

Are We Producing Innovators and Leaders or Change Resisters and Followers?

R. Brueggemeier, M. Speedie, C. K. Svensson, 2012, American Journal of Pharmaceutical Education.

Enzyme-Mediated Protein Haptenation of Dapsone and Sulfamethoxazole in Human Keratinocytes: II. Expression and Role of Flavin-Containing Monooxygenases and Peroxidases

David E. Williams, S. B. Koukouritaki, R. Hines, 2006, Journal of Pharmacology and Experimental Therapeutics.

Free drug concentration monitoring in clinical practice. Rationale and current status.

M. Woodruff, C. K. Svensson, D. Lalka, 1986, Clinical pharmacokinetics.

Pharmacogenomics of acetaminophen in pediatric populations: a moving target

G. Knipp, Wanqing Liu, C. K. Svensson, 2014, Front. Genet..

Arylacetamide deacetylase activity towards monoacetyldapsone. Species comparison, factors that influence activity, and comparison with 2-acetylaminofluorene and p-nitrophenyl acetate hydrolysis.

C. K. Svensson, C. V. Preuss, C. Svensson, 1996, Biochemical pharmacology.

Bioimpedance Assessment of Antipyrine Pharmacokinetics before and after Enzyme Induction

B. Zarowitz, J. Popovich, Edward L. Peterson, 1990, DICP : the annals of pharmacotherapy.

Physiochemical and Biochemical Factors Influencing the Pharmacokinetics of Antibody Therapeutics

F. Theil, L. Khawli, J. Balthasar, 2012, The AAPS Journal.

Immune response to xenobiotics in the skin: from contact sensitivity to drug allergy

F. Khan, A. Gaspari, S. Roychowdhury, 2006, Expert opinion on drug metabolism & toxicology.

Vancomycin pharmacokinetics in burn patients and intravenous drug abusers

M. Rybak, L. Warbasse, C. K. Svensson, 1990, Antimicrobial Agents and Chemotherapy.

A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions.

P. Woster, L. Lash, M. Doll, 2000, The Journal of investigative dermatology.

CBD for the treatment of pain: What is the evidence?

C. Svensson, 2020, Journal of the American Pharmacists Association : JAPhA.

Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin

S. Roychowdhury, C. K. Svensson, C. Svensson, 2005, The AAPS Journal.

Effect of Arylhydroxylamine Metabolites of Sulfamethoxazole and Dapsone on Stress Signal Expression in Human Keratinocytes

F. Khan, A. Gaspari, C. K. Svensson, 2007, Journal of Pharmacology and Experimental Therapeutics.

Effect of pro-inflammatory cytokines on the toxicity of the arylhydroxylamine metabolites of sulphamethoxazole and dapsone in normal human keratinocytes.

P. Woster, F. Khan, S. Roychowdhury, 2006, Toxicology.

Physiochemical and Biochemical Factors Influencing the Pharmacokinetics of Antibody Therapeutics

Daniela Bumbaca, F. Theil, L. Khawli, 2012, The AAPS Journal.

Acetyl CoA:arylamine N-acetyltransferase activity in rat hepatocytes cultured on different extracellular matrices.

W. Lindblad, M. Doll, D. Hein, 1997, Toxicology in vitro : an international journal published in association with BIBRA.

Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions.

P. Woster, T. Reilly, C. K. Svensson, 1999, The Journal of pharmacology and experimental therapeutics.

Disposition of Procainamide in Patients with Chronic Congestive Heart Failure Receiving Medical Therapy

J. Ware, M. Rudis, B. Zarowitz, 1996, Journal of clinical pharmacology.

Effect of amiodarone on the disposition of procainamide in the rat.

C. K. Svensson, P. Knowlton, L. L. Liu, 1988, Journal of pharmaceutical sciences.

Effect of streptolysin-O-on rat hepatic acetyl coenzyme-A: arylamine N-acetyltransferase and cytochrome P-450 2B 1/2 activities ex vivo.

C. K. Svensson, R. Drobitch, P. Divakaruni, 1998, Immunopharmacology and immunotoxicology.

Immunomodulation and drug acetylation: influence of the immunomodulator tilorone on hepatic, renal and blood N-acetyltransferase activity and on hepatic cytosolic acetyl coenzyme A content.

C. K. Svensson, M. Tomilo, R. Drobitch, 1992, Biochemical pharmacology.

Clinical Pharmacokinetics of Nicotine

C. K. Svensson, C. Svensson, 1987, Clinical pharmacokinetics.

Effect of Amiodarone and Desethylamiodarone on the Pharmacokinetics of Antipyrine in the Rat

C. K. Svensson, P. Knowlton, Li-Ling Liu, 1987, Pharmaceutical Research.

Effect of food on hepatic blood flow: Implications in the “food effect” phenomenon

E. Middleton, R. Lanc, D. Edwards, 1983, Clinical pharmacology and therapeutics.

Inhibition of Drug Metabolism by Quinolone Antibiotics

S. Bowles, M. Rybak, D. Edwards, 1988, Clinical pharmacokinetics.

Acetylator Phenotype and Genotype in HIV‐Infected Patients with and without Sulfonamide Hypersensitivity

R. MacArthur, M. Doll, D. Hein, 2002, Journal of clinical pharmacology.

Effect of glutathione depletion on the in vivo inhibition of drug metabolism by agents forming an inactive cytochrome P-450 Fe(II):metabolite complex. Studies with amiodarone and troleandomycin.

C. K. Svensson, R. Drobitch, K. A. Kloss, 1991, Journal of pharmaceutical sciences.